1. Home
  2. KTTA vs CYN Comparison

KTTA vs CYN Comparison

Compare KTTA & CYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pasithea Therapeutics Corp.

KTTA

Pasithea Therapeutics Corp.

HOLD

Current Price

$0.54

Market Cap

23.2M

Sector

Health Care

ML Signal

HOLD

Logo Cyngn Inc.

CYN

Cyngn Inc.

HOLD

Current Price

$1.20

Market Cap

22.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
KTTA
CYN
Founded
2020
2013
Country
United States
United States
Employees
5
62
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
23.2M
22.9M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
KTTA
CYN
Price
$0.54
$1.20
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
436.1K
222.3K
Earning Date
05-14-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$368,138.00
Revenue This Year
N/A
$3,359.28
Revenue Next Year
N/A
$347.47
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.28
$1.10
52 Week High
$2.06
$17.20

Technical Indicators

Market Signals
Indicator
KTTA
CYN
Relative Strength Index (RSI) 35.96 37.37
Support Level $0.49 N/A
Resistance Level $0.76 $1.76
Average True Range (ATR) 0.05 0.08
MACD 0.00 -0.00
Stochastic Oscillator 37.62 33.78

Price Performance

Historical Comparison
KTTA
CYN

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. The disorders covered includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module). The Company has reportable segment, which is the business of research and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers.

About CYN Cyngn Inc.

Cyngn Inc is an industrial autonomous vehicle technology company, focused on addressing industrial uses for autonomous vehicles. It develops full-stack autonomous driving software, DriveMod, which is integrated into vehicles manufactured by original equipment manufacturers during the assembly process. The company designs its software to be compatible with a range of sensors and hardware components and integrates it with its own systems to enable autonomous vehicle functionality.

Share on Social Networks: